|
| Status |
Public on Oct 13, 2021 |
| Title |
BM_Rux_D3_rep1 |
| Sample type |
RNA |
| |
|
| Source name |
C57BL/6 mouse BM 3 day post treatment with ruxolitinib
|
| Organism |
Mus musculus |
| Characteristics |
strain: C57BL/6
tissue: bone marrow
gender: Female
age: 6-8 weeks
treatment: Ruxolitinib
days post drug treatment: 3
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA extracted using Qiagen Rneasy kit
|
| Label |
Nanostring ncounter probes
|
| Label protocol |
as per manufacturers instructions
|
| |
|
| Hybridization protocol |
as per manufacturers instructions
|
| Scan protocol |
as per manufacturers instructions
|
| Data processing |
Analysed using nCounter Advanced Analysis (version 2.0.115; NanoString Technologies) as per manufacturers instructions
|
| |
|
| Submission date |
Jul 28, 2021 |
| Last update date |
Oct 13, 2021 |
| Contact name |
Rachel M Koldej |
| E-mail(s) |
rachel.koldej@mh.org.au
|
| Organization name |
Melbourne Health
|
| Street address |
305 Grattan St
|
| City |
Melbourne |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Platform ID |
GPL30298 |
| Series (1) |
| GSE181060 |
Immune profiling in mice treated with BCL2 or JAK1/2 inhibitors |
|
